Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies

Journal of Infectious Diseases

Volumn 186, Issue 5, 2002, Pages 598-605

  Wang, Sophia S ^a   Hildesheim, Allan ^a   Gao, Xiaojiang ^b   Schiffman, Mark ^a   Herrero, Rolando ^k   Bratti, M Concepcion ^k   Sherman, Mark E ^a   Barnes, Willard A ^d   Greenberg, Mitchell D ^f   Mc Gowan, Larry ^e   Mortel, Rodrigue ^g   Schwartz, Peter E ^h   Zaino, Richard J ^g   Glass, Andrew G ⁱ   Burk, Robert D ^j   Karacki, Peter ^c   Carrington, Mary ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

^e GEORGE WASHINGTON UNIVERSITY   (United States)

^f GRADUATE HOSPITAL   (United States)

^g PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^h YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ KAISER PERMANENTE   (United States)

^j ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^k NONE   (Costa Rica)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; HLA C ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

ALLELE; ARTICLE; CANCER CYTODIAGNOSIS; CANCER EPIDEMIOLOGY; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIUM CELL; FEMALE; HLA SYSTEM; HLA TYPING; HUMAN; HYPOTHESIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NATURAL KILLER CELL; PAPILLOMA VIRUS; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; VIRUS INFECTION;

ALLELES; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; COSTA RICA; DNA, VIRAL; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-C ANTIGENS; HUMANS; LOGISTIC MODELS; OREGON; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0036721095     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/342295     Document Type: Article

References (28)

1. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity
2. Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma
3. Association between HLA DQB1*0 and cervical intraepithelial neoplasia
4. Lack of association of HLA polymorphisms with human papillomavirus-related cervical cancer
5. Association between HLA-DQB1 alleles and risk for cervical cancer in African-American women
6. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3
7. Cervical intraepithelial neoplasia, cervical carcinoma, and risk for patients with HLA-DQB1*0602, *301, *0303 alleles
8. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women
9. T-cell proliferative response to human papillomavirus type 16 peptides: Relationship to cervical intraepithelial neoplasia
10. Cytotoxic T lymphocyte response to E6 and E7 proteins of human papillomavirus type 16: Relationship to cervical intraepithelial neoplasia
11. Loss of MHC class-I expression in cervical carcinomas
12. HLA expression in pre-invasive cervical neoplasia in relation to human papilloma virus infection
13. MHC class I expression in HPV 16 positive cervical carcinomas is post-transcriptionally controlled and independent from c-myc overexpression
14. Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions
15. HLA class I/II alleles and development of HPV-related cervical neoplasia: Results from a case-control study conducted in the United States
16. Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: Results from a population-based study in Costa Rica
17. Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: The Guanacaste project
18. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas
19. Population stratification in epidemiologic studies of common genetic variants and cancer: Quantification of bias
20. HLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines
21. Human leukocyte antigen class I gene mutations in cervical cancer
22. Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer
23. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours